Kallikrein 9 Antibody [DyLight 350]

• Reactivity: Hu
• Applications: WB, IHC, IP
• Clonality: Polyclonal
• Host: Goat
• Conjugate: DyLight 350

Kallikrein 9 Antibody [DyLight 350] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human Kallikrein 9
  Asp20-Asn250
  Accession # Q9UKQ9
• Specificity: Detects human Kallikrein 9 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant human KLK-1, -3, -4, -5, -6, -7, -8, -10, -11, -12, -13, -14, and -15 is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Gene: KLK9
• Purity: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry
  • Immunoprecipitation
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Antigen Affinity-purified

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for Kallikrein 9 Antibody [DyLight 350]

• EC 3.4.21
• EC 3.4.21.-
• EC 3.4.21.4
• Kallikrein 9
• Kallikrein-like protein 3
• kallikrein-related peptidase 9
• KLK9
• KLKL3
• KLK-L3
• KLK-L3kallikrein-9
• MGC50513

Background

Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. (KLK-L3; HGMW-approved symbol KLK9) is a novel kallikrein gene with utility for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: KLK9